A nurse is caring for a client who has degenerative disc disease and has been diagnosed with cauda equine syndrome. Which of the following would be an expected finding with this condition?
Paralytic lleus
Blood pressure 80/48 mm Hg
Weakness in one or both legs
Potassium 3.2 mEq/L
The Correct Answer is C
Choice A Reason:
Paralytic ileus is incorrect. Paralytic ileus is a condition characterized by obstruction of the intestines due to paralysis of the intestinal muscles, resulting in symptoms such as abdominal pain, bloating, and constipation. Paralytic ileus is not typically associated with cauda equina syndrome, which primarily affects the nerves in the lower back and lower extremities.
Choice B Reason:
Blood pressure 80/48 mm Hg is incorrect. While cauda equina syndrome can cause neurological symptoms such as lower extremity weakness, numbness, and bowel or bladder dysfunction, it is not typically associated with alterations in blood pressure. Blood pressure changes may occur in response to pain or other systemic factors, but they are not specific to cauda equina syndrome.
Choice C Reason:
Weakness in one or both legs is correct. Yes, weakness in one or both legs is a characteristic finding of cauda equina syndrome. Compression of the nerve roots in the lower spinal cord can lead to motor deficits, including weakness, difficulty walking, and loss of reflexes in the lower extremities.
Choice D Reason:
Potassium 3.2 mEq/L is incorrect. Serum potassium levels are not typically associated with cauda equina syndrome. Abnormal potassium levels may be indicative of electrolyte imbalances, which can occur in various medical conditions but are not specific to cauda equina syndrome.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is ["B","C","D","E","F"]
Explanation
Choice A Reason:
Easily getting back to sleep after awakening is incorrect. This is not typically a manifestation of obstructive sleep apnea. Instead, individuals with OSA often experience fragmented sleep due to frequent awakenings caused by apnea episodes.
Choice B Reason:
Many episodes of apnea per night is correct. Yes, individuals with obstructive sleep apnea experience many episodes of apnea (complete cessation of breathing) or hypopnea (partial obstruction of airflow) per night. These episodes can occur multiple times throughout the night, disrupting normal sleep patterns.
Choice C Reason:
Loud snort after breathing cessation is correct. This is a characteristic manifestation of obstructive sleep apnea. Individuals with OSA often make choking, snorting, or gasping sounds after a period of breathing cessation as they attempt to resume breathing.
Choice D Reason:
10 seconds or longer of breathing cessation is correct. Yes, breathing cessation episodes in obstructive sleep apnea typically last for 10 seconds or longer. These prolonged episodes of apnea contribute to oxygen desaturation and disrupted sleep.
Choice E Reason:
Daytime sleepiness is correct. Yes, daytime sleepiness is a common symptom of obstructive sleep apnea. Disrupted sleep patterns and frequent awakenings during the night can lead to excessive daytime sleepiness, fatigue, and decreased alertness.
Choice F Reason:
Frequent, loud snoring is correct. Yes, frequent, loud snoring is a hallmark symptom of obstructive sleep apnea. Snoring occurs due to the partial obstruction of airflow in the upper airway during sleep.
Correct Answer is D
Explanation
Choice A Reason:
Dulaglutide is inappropriate. Dulaglutide is a medication used to treat type 2 diabetes by improving blood sugar control. It is not indicated for the management of neurogenic bladder or urinary incontinence.
Choice B Reason:
Montelukast sodium is inappropriate. Montelukast sodium is a medication primarily used to treat asthma and allergic rhinitis by blocking leukotrienes, which are inflammatory substances that contribute to asthma and allergy symptoms. It is not indicated for the management of neurogenic bladder or urinary incontinence.
Choice C Reason:
Glatiramer acetate is inappropriate. Glatiramer acetate is a medication used to treat relapsing-remitting multiple sclerosis (MS) by modulating the immune system. It is not indicated for the management of neurogenic bladder or urinary incontinence.
Choice D Reason:
Oxybutynin is appropriate. Oxybutynin is a medication commonly prescribed for the management of neurogenic bladder and urinary incontinence. It belongs to a class of medications called anticholinergics, which work by relaxing the bladder muscles and reducing bladder spasms. Oxybutynin helps control urinary urgency, frequency, and incontinence associated with neurogenic bladder, including spasm-induced incontinence.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today